Insider filing · STOK
Stoke Therapeutics, Inc.
STOK · Healthcare · 35 filings in 24 months
ticker →
Blue Horizon Enterprise Ltd sold $23.0M of Stoke Therapeutics (STOK)
Executed Dec 23 2024, disclosed Dec 27 2024, 4 days later, against a two-business-day limit.
Value, as filed
$23.0M
2,000,000 sh × $11.50
Executed
Dec 23 2024
the trade date, as filed
Disclosed
Dec 27 2024
4 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
BL
Blue Horizon Enterprise Ltd
10% owner
profile →
Blue Horizon Enterprise Ltd (10% owner) filed 2 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 2 sales, 1 filed past the two-business-day deadline), most often in Stoke Therapeutics, Inc. (STOK). The largest single filing was $23.0M of STOK (2,000,000 sh × $11.50, as filed), executed Dec 23 2024.
The name
STOKHealthcare · Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Blue Horizon Enterprise Ltd in STOK
STOKSALE
Stoke Therapeutics, Inc.
$27.2M1,937,500 sh × $14.05
Exec Sep 19 2024
Filed Sep 23 2024 · 5:30 PM ET